When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)
- 28 February 2009
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 5 (4) , 255-262
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Identification of Progenitor Cells That Contribute to Heterotopic SkeletogenesisJournal of Bone and Joint Surgery, 2009
- Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans ProgressivaJournal of Biological Chemistry, 2009
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Early Diagnosis of Fibrodysplasia Ossificans ProgressivaPediatrics, 2008
- Dysregulated BMP Signaling and Enhanced Osteogenic Differentiation of Connective Tissue Progenitor Cells From Patients With Fibrodysplasia Ossificans Progressiva (FOP)Journal of Bone and Mineral Research, 2008
- Fibrodysplasia ossificans progressivaBest Practice & Research Clinical Rheumatology, 2008
- Proximal Tibial Osteochondromas in Patients with Fibrodysplasia Ossificans ProgressivaJournal of Bone and Joint Surgery, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Hypoxic Adipocytes Pattern Early Heterotopic Bone FormationThe American Journal of Pathology, 2007
- The TGFβ Receptor Activation ProcessMolecular Cell, 2001